Usual Dose of Naltrexone
For alcohol use disorder, the standard dose is 50 mg once daily by mouth, or 380 mg intramuscularly once monthly. 1
Oral Naltrexone Dosing
For Alcohol Use Disorder
- Standard dose: 50 mg once daily 1
- This dosing regimen was validated in placebo-controlled trials demonstrating efficacy for up to 12 weeks 1
- The 50 mg daily dose has a number needed to treat of 18 to prevent one person from returning to any drinking, and 11 to prevent return to heavy drinking 2
For Opioid Dependence
- Initial dose: 25 mg on day 1 to assess for precipitated withdrawal 1
- Maintenance dose: 50 mg once daily if no withdrawal signs occur 1
- This dose provides adequate clinical blockade of parenterally administered opioids 1
Alternative Dosing Schedules
For supervised administration settings, flexible regimens may be used 1:
- 50 mg every weekday with 100 mg on Saturday
- 100 mg every other day
- 150 mg every third day
Important caveat: Single doses above 50 mg carry higher risk of hepatocellular injury, so extended dosing intervals should balance risks against benefits 1
Injectable Naltrexone Dosing
For Alcohol Use Disorder
- 380 mg intramuscularly once monthly (Vivitrol) 3
- This formulation resulted in a 25% decrease in heavy drinking days compared to placebo 4
- Injectable naltrexone reduced drinking days by approximately 5 days over a 30-day period 5
- The monthly injection addresses adherence challenges inherent to daily oral therapy 4
For Opioid Dependence
- 380 mg intramuscularly once monthly 3
- FDA-approved for this indication following approval for alcohol dependence 3
Critical Pre-Treatment Requirements
Patients must be opioid-free before starting naltrexone to avoid precipitated withdrawal 1:
- Minimum 7-10 days opioid-free for short-acting opioids 1
- Patients transitioning from buprenorphine or methadone may be vulnerable to precipitated withdrawal for up to 2 weeks 1
- Consider naloxone challenge test if occult opioid dependence is suspected 1
Monitoring Requirements
- Baseline liver function tests and repeat every 3-6 months 3
- Naltrexone has been associated with hepatic injury at supratherapeutic doses 3
- Recent evidence suggests naltrexone is safe even in patients with severe alcohol-associated cirrhosis 6
Clinical Context
Naltrexone should be part of a comprehensive treatment plan including psychosocial interventions 1. The medication works by blocking mu-opioid receptors, preventing the euphoric effects of alcohol and opioids and reducing craving 3. Evidence supports both oral naltrexone at 50 mg daily and acamprosate as first-line pharmacotherapies for alcohol use disorder when combined with psychosocial support 2.
For perioperative management, oral naltrexone should be held 2-3 days before elective surgery if opioids will be needed, while injectable naltrexone requires 24-30 days after the last injection 5.